April 25, 2016.
Following their refusal to comment Friday on "rumors" that CEO Joseph Papa was leaving to head Valeant Pharmaceuticals, Dublin-based Perrigo has today confirmed the rumor's truth in announcing the appointment of John T. Hendrickson as Perrigo's Chief Executive Officer, "effective immediately, following the resignation and departure of Joseph C. Papa".
Hendrickson has served as President of Perrigo since October 2015. He was formerly Executive Vice President, Global Operations & Supply Chain between 2006 and 2015. Meanwhile, Valeant announced today that Papa tis expected to join the company as Chairman and CEO by early May.
Can Data and AI Deliver Whole-Person Health?
July 9th 2024Executives in the life sciences and medical device industries see promise in artificial intelligence (AI) and medical technologies, but must also navigate the changing healthcare ecosystem, varied stakeholder needs, and the impact of AI on market access and commercialization strategies.